Autonomic disorders against the background of chronic bilateral electrostimulation of the subthalamic nucleus in Parkinson's disease (literature review)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Parkinson’s disease (PD) is characterized by motor, autonomic disorders, and other non-motor symptoms. Cardiovascular, urinary, gastrointestinal and thermoregulatory disorders predominate among autonomic disturbances. Due to the significant impact on the quality of life of PD patients, adequate diagnostics and treatment of autonomic disorders should be carried out timely at all stages of the disease. Subthalamic deep brain stimulation (STN DBS) is one of the high effective methods of treating motor symptoms in patients with an advanced PD. In addition to improving motor symptoms, many studies report a change in severity of various autonomic symptoms after STN DBS in PD patients.

全文:

受限制的访问

作者简介

M. Makhmudov

Russian Medical Academy of Continuous Professional Education

Department of Neurology

N. Fedorova

Russian Medical Academy of Continuous Professional Education

Department of Neurology

E. Bril

Russian Medical Academy of Continuous Professional Education

Email: e.biiH@inbox.ru
Associate Professor, Department of Neurology

A. Gamaleya

N.N. Burdenko National Medical Research Center of Neurosurgery

A. Tomsky

N.N. Burdenko National Medical Research Center of Neurosurgery

参考

  1. Левин О.С., Федорова Н.В. Болезнь Паркинсона. М., 2016. С. 8-43. [Levin O.S., Fedorova N.V Parkinsons Disease. M., 2016. P 8-43. (In Russ.)].
  2. Раздорская В.В., Воскресенская О.Н., Юдина ГК Болезнь Паркинсона в России: распространенность и заболеваемость. Саратовский научномедицинский журнал. 2016;12(3):379-84. [Razdorskaya V.V., VoskresenskayaO.N., YudinaG.K Parkinson's disease: prevalence and incidence. Saratovskii nauchno-meditsinskii zhurnal. 2016;12(3):379-84. (In Russ.)].
  3. Dorsey E, Constantinescu R., Thompson J., et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2006;68(5):384-86. DOI: https://doi. org/10.1212/01.wnl.0000247740.47667.03.
  4. Mansouri A., Taslimi S., Badhiwala J., et al. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018;128(4):1199-213. DOI: https://doi. org/10.3171/2016.11.jns16715.
  5. Гамалея А.А, Томский А.А., Бриль Е.В., Шабалов В.А. Электростимуляция глубоких структур головного мозга при экстрапирамидных заболеваниях. Принципы программирования. Нервные болезни. 2012;4:55-62.
  6. Алимова Е.А., Голубев В.Л. Вегетативные наруше -ния при паркинсонизме. Журн. невропатологии и психиатрии. 1992;92(5):48-52. [Alimova E.A., Golubev VL. Autonomic dysfunction in parkinsonism. Zhurnal nevropatologii i psikhiatrii. 1992;92(5):48-52. (In Russ.)].
  7. Verhagen L, Barton B. Faculty of 1000 evaluation for The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. F1000 - Post-publication peer review of the biomedical literature. 2009. Doi: https://doi.org/10.3410/f.1168078.630196.
  8. Byrne K, Pfeiffer R., Quigley E. Gastrointestinal Dysfunction in Parkinsons Disease. J. Clin. Gastroenterol. 1994;19(1):11-6. Doi: https://doi. org/10.1097/00004836-199407000-00004.
  9. Fischer M., Gemende I., Marsch W., Fischer P. Skin function and skin disorders in Parkinson's disease. J Neural Transm. 2001;108(2):205-13. Doi: https://doi.org/10.1007/s007020170088.
  10. Pathak A., Senard J. Blood pressure disorders during Parkinson's disease: epidemiology, pathophysiology and management. Expert Rev Neurother. 2006;6(8):1173-80. Doi: https://doi. org/10.1586/14737175.6.8.1173.
  11. Sakakibara R., Uchiyama T., Yamanishi T., Kishi M. Genitourinary dysfunction in Parkinson's disease. Movement Disorders. 2010;25(1):2-12. Doi: https://doi.org/10.1002/mds.22519.
  12. Jager W., Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J. Neurol Neurosurg Psychiat. 1960;23(4):283-90. Doi: https://doi. org/10.1136/jnnp.23.4.283.
  13. Palma J., Kaufmann H. Autonomic disorders predicting Parkinson's disease. Parkinsonism Relat Disord. 2014;20:94-8. Doi: https://doi. org/10.1016/s1353-8020(13)70024-5.
  14. Visser M., Marinus J., Stiggelbout A., Van Hilten J. Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT. Movement Disorders. 2004;19(11):1306-12. Doi: https:// doi.org/10.1002/mds.20153.
  15. Martinez-Martin P., Chaudhuri K., Rojo-Abuin J., et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J. Neurol. 2013;22(1):37-43. Doi: https://doi. org/10.1111/ene.12165.
  16. Chaudhuri K., Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson's disease. Eur J. Neurol. 2008;15:2-8. Doi: https://doi. org/10.1111/j.1468-1331.2008.02212.x.
  17. Федорова Н.В., Яблонская А.Ю. Шкала для оценки вегетативных нарушений у пациентов с болезнью. М., 2011. P. 24-30.
  18. Левин О.С. Неотложные состояния у пациентов с болезнью Паркинсона. Трудный пациент. 2007;5(6-7):19-25.
  19. Braak H., Braak E. Pathoanatomy of Parkinson’s disease. J. Neurol. 2000;247(Suppl. 2):3-10. Doi: https://doi.org/10.1007/pl00007758.
  20. Ludwig J., Remien P., Guballa C., et al. Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson’s disease. J. Neurol Neurosurg. Psychiat. 2006;78(7):742-5. Doi: https://doi. org/10.1136/jnnp.2006.103739.
  21. Halim A., Baumgartner L., Binder D. Effect of deep brain stimulation on autonomic dysfunction in patients with Parkinson’s disease. J. Clin Neurosci. 2011;18(6):804-6. Doi: https://doi. org/10.1016/j.jocn.2010.10.015.
  22. Lim S., Fox S., Lang A. Overview of the Extranigral Aspects of Parkinson Disease. Arch. Neurol. 2009;66(2). Doi: https://doi.org/10.1001/ archneurol.2008.561.
  23. Lim S., Lang A. The nonmotor symptoms of Parkinson’s disease-An overview. Movement Disorders. 2010;25(Suppl. 1):123-30. Doi: https://doi.org/10.1002/mds.22786.
  24. Castrioto A., Lhommee E., Moro E., Krack P. Mood and behavioural effects of subthalamic stimulation in Parkinson’s disease. Lancet Neurol. 2014;13(3):287-305. Doi: https://doi. org/10.1016/s1474-4422 (13)70294-1.
  25. Strano S., Fanciulli A., Rizzo M., et al. Cardiovascular dysfunction in untreated Parkinson’s disease: A multi-modality assessment. J. Neurol Sci. 2016;370:251-55. Doi: https://doi. org/10.1016/j.jns.2016.09.036.
  26. Allcock L. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease. J. Neurol Neurosurg Psychiat. 2004;75(10): 1470-71. Doi: https://doi. org/10.1136/jnnp.2003.029413.
  27. Magerkurth C., Schnitzer R., Braune S. Symptoms of autonomic failure in Parkinson?s disease: prevalence and impact on daily life. Clin Autonomic Res. 2005;15(2):76-82. Doi: https://doi. org/10.1007/s10286-005-0253-z.
  28. Jost W. Autonome Regulationsstorungen beim Parkinson-Syndrom. Fortschrit. Neurol Psychiat. 1995;63(05):194-205. Doi: https://doi. org/10.1055/s-2007-996616.
  29. Kaufmann H., Bhattacharya K., Voustianiouk A., Gracies J. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurol. 2002;59(10): 1657-57. Doi: https://doi.org/10.1212/01. wnl.0000034180.21308.c0.
  30. Stemper B., Beric A., Welsch G., et al. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease. Neurol. 2006;67(10): 1781-85. Doi: https://doi. org/10.1212/01.wnl.0000244416.30605.f1.
  31. Tateno F, Sakakibara R., Nagao T., et al. Deep Brain Stimulation Ameliorates Postural Hypotension in Parkinson's Disease. J Am Geriatr Soc. 2015;63(10):2186-89. Doi: https://doi. org/10.1111/jgs.13674.
  32. Holmberg B., Corneliusson O., Elam M. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: No effects on, and of, autonomic dysfunction. Movement Disorders. 2005;20(8):976-81. Doi: https://doi. org/10.1002/mds.20492.
  33. Erola T, Haapaniemi T., Heikkinen E., et al. Subthalamic nucleus deep brain stimulation does not alter long-term heart rate variability in Parkinson's disease. Clin Autonom Res. 2006;16(4):286-88. Doi: https://doi.org/10.1007/s10286-006-0354-3
  34. Merola A, Zibetti M., Angrisano S., et al. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain. 2011;134(7):2074-84. Doi: https://doi. org/10.1093/brain/awr121
  35. Edwards L, Pfeiffer R., Quigley E., et al. Gastrointestinal symptoms in Parkinson's disease. Movement Disorders. 1991;6(2):151-56. Doi: https://doi.org/10.W02/mds.870060211.
  36. Pfeiffer R. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003;2(2):107-16. Doi: https://doi.org/10.1016/s1474-4422(03)00307-7.
  37. Arai E., Arai M., Uchiyama T., et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012;135(5):147-85. Doi: https://doi.org/10.1093/brain/aws086.
  38. Chou K., Taylor J., Patil P. The MDS-UPDRS tracks motor and non-motor improvement due to subthalamic nucleus deep brain stimulation in Parkinson disease. Parkinsonism Relat Disord. 2013;19(11):966-69. Doi: https://doi. org/10.1016/j.parkreldis.2013.06.010.
  39. Chaudhuri K., Odin P, Antonini A., Martinez-Martin P. Parkinson's disease: The non-motor issues. Parkinsonism Relat Disord. 2011;17(10):717 23. Doi: https://doi.org/10.1016/j. parkreldis.2011.02.018
  40. Petrovitch H., Abbott R., Ross G., et al. Bowel movement frequency in late-life and substantia nigra neuron density at death. Movement Disorders. 2008;24(3):371-76. Doi: https://doi. org/10.1002/mds.22360.
  41. Zibetti M., Torre E., Cinquepalmi A., et al. Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus. Eur Neurol. 2007;58(4):218-23. Doi: https://doi. org/10.1159/000107943.
  42. Mridula K.R., Borgohain R., Jabeen S.A., et al. Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study. Iran J. Neurol. 2015;14(2):86.
  43. Rizzone M., Fasano A., Daniele A., et al. longterm outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease? Parkinsonism Relat Disord. 2014;20(4):376 81. Doi: https://doi.org/10.1016/j.parkreldis. 2014.01.012
  44. Pursiainen V, Haapaniemi T., Korpelainen J., et al. Sweating in Parkinsonian patients with wearing-off. Movement Disorders. 2007;22(6):828-32. DOI: https://doi.org/10.1002/mds.21422
  45. Witjas T., Kaphan E., Azulay J., et al. Nonmotor fluctuations in Parkinson's disease: Frequent and disabling. Neurol. 2002;59(3):408-13. Doi: https://doi.org/10.1212/wnl.59.3.408
  46. Trachani E., Constantoyannis C., Sirrou V, et al. Effects of subthalamic nucleus deep brain stimulation on sweating function in Parkinson's disease. Clin Neurol Neurosurg. 2010;112(3):213-17. Doi: https://doi.org/10.1016/j.clineuro.2009.11.015
  47. Araki I., Kitaharam O.T., Kuno S. Voiding disfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000;164(5):1640 43. Doi: https://doi.org/10.1016/s0022-5347(05)67048-6
  48. Bronner G., Royter V., Korczyna A., Giladin. Sexual Dysfunction in Parkinson's Disease. J. Sex Marital Ther. 2004;30(2):95-105. Doi: https://doi. org/10.1080/00926230490258893.
  49. Хитаришвили Э.В., Федорова Н.В., Кулуа Т.К. и др. Нарушения мочеиспускания у больных болезнью Паркинсона и методы их коррекции. Неврологический журнал. 2005;10(3):28-34.
  50. Jost W. Urological problems in Parkinson's disease: clinical aspects. J. Neural Transm. 2012;120(4):587-91. Doi: https://doi. org/10.1007/s00702-012-0914-8.
  51. Brusa L., Petta F., Pisani A., et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurol. 2007;68(18):1455-59. Doi: https://doi. org/10.1212/01.wnl.0000260605.12506.86.
  52. Balash Y., Peretz C., leibovich G., et al. Falls in outpatients with Parkinson's disease. J. Neurol. 2005;252( 11):1310-15. Doi: https://doi. org/10.1007/s00415-005-0855-3.
  53. Finazzi-Agro E., Peppe A., D'Amico A., et al. Effects of Subthalamic Nucleus Stimulation on Urodynamic Findings in Patients with Parkinson's Disease. J. Urol. 2003; 169(4):1388-91. Doi: https://doi. org/10.1097/01.ju.0000055520.88377.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2019
##common.cookie##